Tag: Optimed
STEVECO trial catalyzes need for “a new era” of post-thrombotic syndrome...
This advertorial is sponsored by Optimed.
Before the STEVECO trial, there were no randomized controlled trial data in the chronic disease space; in its wake, has...
STEVECO trial provides “important evidence” in quest for individualized venous treatment
This advertorial, sponsored by Optimed, is only available in selected countries and geographies.
One-year results from the STEVECO randomized controlled trial (RCT) were recently...
STEVECO trial calls into question randomisation in the venous stenting field
Recruitment proved to be a major challenge for the STEVECO (Stent versus conservative treatment in patients with deep venous obstruction) randomised controlled trial (RCT),...
Optimed announces the presentation of two prospective venous stent trials at...
Optimed recently announced the presentation of two prospective, multicentre trials evaluating the performance and effectiveness of their venous stent systems at the Leipzig Interventional...